AAAAAA

   
Results: 1-7 |
Results: 7
Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1
Authors: Dhanak, D Christmann, LT Darcy, MG Jurewicz, AJ Keenan, RM Lee, J Sarau, HM Widdowson, KL White, JR
Citation: D. Dhanak et al., Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1, BIOORG MED, 11(11), 2001, pp. 1441-1444
Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2
Authors: Dhanak, D Christmann, LT Darcy, MG Keenan, RM Knight, SD Lee, J Ridgers, LH Sarau, HM Shah, DH White, JR Zhang, LL
Citation: D. Dhanak et al., Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2, BIOORG MED, 11(11), 2001, pp. 1445-1450
Base induced reaction of an azetidin-2-one: Formation of a novel [1,4]-diazepinedione
Authors: Dhanak, D Hickey, DMB Meeson, ML Elliott, RL Shore, AD Haltiwanger, RC
Citation: D. Dhanak et al., Base induced reaction of an azetidin-2-one: Formation of a novel [1,4]-diazepinedione, SYN COMMUN, 31(17), 2001, pp. 2713-2718
Metal mediated protease inhibition: Design and synthesis of inhibitors of the human cytomegalovirus (hCMV) protease
Authors: Dhanak, D Burton, G Christmann, LT Darcy, MG Elrod, KC Kaura, A Keenan, RM Link, JO Peishoff, CE Shah, DH
Citation: D. Dhanak et al., Metal mediated protease inhibition: Design and synthesis of inhibitors of the human cytomegalovirus (hCMV) protease, BIOORG MED, 10(20), 2000, pp. 2279-2282
Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration
Authors: White, JR Lee, JM Dede, K Imburgia, CS Jurewicz, AJ Chan, G Fornwald, JA Dhanak, D Christmann, LT Darcy, MG Widdowson, KL Foley, JJ Schmidt, DB Sarau, HM
Citation: Jr. White et al., Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration, J BIOL CHEM, 275(47), 2000, pp. 36626-36631
Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor
Authors: Macphee, CH Moores, KE Boyd, HF Dhanak, D Ife, RJ Leach, CA Leake, DS Milliner, KJ Patterson, RA Suckling, KE Tew, DG Hickey, DMB
Citation: Ch. Macphee et al., Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor, BIOCHEM J, 338, 1999, pp. 479-487
Benzothiopyran-4-one based reversible inhibitors of the human cytomegalovirus (HCMV) protease
Authors: Dhanak, D Keenan, RM Burton, G Kaura, A Darcy, MG Shah, DH Ridgers, LH Breen, A Lavery, P Tew, DG West, A
Citation: D. Dhanak et al., Benzothiopyran-4-one based reversible inhibitors of the human cytomegalovirus (HCMV) protease, BIOORG MED, 8(24), 1998, pp. 3677-3682
Risultati: 1-7 |